#vivani — Public Fediverse posts

https://www.europesays.com/dk/130237/ Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal #AdamMendelsohn #Company #Mendelsohn #NovoNordisk #Vivani #VivaniMedical #VivaniMedicalSurges

https://www.europesays.com/dk/129169/ Novo Nordisk signs pact to assess semaglutide implant #AdamMendelsohn #NovoNordisk #ozempic #Vivani #WeightLoss #WeightManagement

https://www.europesays.com/dk/125995/ Novo Nordisk (CPSE:NOVO B) Teams Up With Vivani To Test A Semaglutide Implant #DrugDelivery #NovoNordisk #ObesityTreatment #Vivani #VivaniMedical #WeightManagement

https://www.europesays.com/dk/125586/ Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant #Development #NovoNordisk #semaglutide #Vivani #VivaniMedical #WeightLoss #WeightManagement

https://www.europesays.com/dk/124524/ Vivani Medical Enters into Agreement with Novo Nordisk to #AdamMendelsohn #GLP1 #Implant #Inc #Nasdaq:VANI #NovoNordisk #Obesity #Research #semaglutide #VANI #Vivani #VivaniMedical #WeightLoss #WeightManagement

https://www.europesays.com/dk/124196/ Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management #A #agreement #Chronic #Enters #Evaluate #for #Implant #into #LongActing #management #medical #Miniature #Nordisk #novo #NovoNordisk #NPM139 #semaglutide #to #Ultra #Vivani #Weight #with

#Cortigent #IPO https://www.sec.gov/Archives/edgar/data/1958489/000175392624002059/g084589_s1a.htm "We anticipate that the initial public offering price of our shares will be $10.00 per share"; 6 employees as of November 1, 2024; #Nasdaq $CRGT #Vivani; #neurostimulation #Orion #BCI #NeuroTech

#Cortigent #IPO https://www.sec.gov/Archives/edgar/data/1958489/000175392624002059/g084589_s1a.htm "We anticipate that the initial public offering price of our shares will be $10.00 per share"; 6 employees as of November 1, 2024; #Nasdaq $CRGT #Vivani; #neurostimulation #Orion #BCI #NeuroTech

#Cortigent #IPO https://www.sec.gov/Archives/edgar/data/1958489/000175392624002059/g084589_s1a.htm "We anticipate that the initial public offering price of our shares will be $10.00 per share"; 6 employees as of November 1, 2024; #Nasdaq $CRGT #Vivani; #neurostimulation #Orion #BCI #NeuroTech

#Cortigent #IPO https://www.sec.gov/Archives/edgar/data/1958489/000175392624002059/g084589_s1a.htm "We anticipate that the initial public offering price of our shares will be $10.00 per share"; 6 employees as of November 1, 2024; #Nasdaq $CRGT #Vivani; #neurostimulation #Orion #BCI #NeuroTech

#Cortigent #IPO https://www.sec.gov/Archives/edgar/data/1958489/000175392624002059/g084589_s1a.htm "We anticipate that the initial public offering price of our shares will be $10.00 per share"; 6 employees as of November 1, 2024; #Nasdaq $CRGT #Vivani; #neurostimulation #Orion #BCI #NeuroTech

On the #Orion brain implant for vision: "In October 2023, #Vivani implemented a reduction-in-force to conserve cash that decreased #Cortigent’s employees from 14 to 7 while continuing the ongoing Orion clinical study and basic operations." https://www.sec.gov/ix?doc=/Archives/edgar/data/1266806/000175392624000616/g084109_10k.htm #BCI #NeuroTech

On the #Orion brain implant for vision: "In October 2023, #Vivani implemented a reduction-in-force to conserve cash that decreased #Cortigent’s employees from 14 to 7 while continuing the ongoing Orion clinical study and basic operations." https://www.sec.gov/ix?doc=/Archives/edgar/data/1266806/000175392624000616/g084109_10k.htm #BCI #NeuroTech

On the #Orion brain implant for vision: "In October 2023, #Vivani implemented a reduction-in-force to conserve cash that decreased #Cortigent’s employees from 14 to 7 while continuing the ongoing Orion clinical study and basic operations." https://www.sec.gov/ix?doc=/Archives/edgar/data/1266806/000175392624000616/g084109_10k.htm #BCI #NeuroTech

On the #Orion brain implant for vision: "In October 2023, #Vivani implemented a reduction-in-force to conserve cash that decreased #Cortigent’s employees from 14 to 7 while continuing the ongoing Orion clinical study and basic operations." https://www.sec.gov/ix?doc=/Archives/edgar/data/1266806/000175392624000616/g084109_10k.htm #BCI #NeuroTech

On the #Orion brain implant for vision: "In October 2023, #Vivani implemented a reduction-in-force to conserve cash that decreased #Cortigent’s employees from 14 to 7 while continuing the ongoing Orion clinical study and basic operations." https://www.sec.gov/ix?doc=/Archives/edgar/data/1266806/000175392624000616/g084109_10k.htm #BCI #NeuroTech

#Vivani #Cortigent is shifting development focus for the #Orion brain implant from a visual cortical prosthesis for the blind towards a stroke recovery system https://www.sec.gov/Archives/edgar/data/1958489/000175392624000605/g084143_s1a.htm $VANI $EYES $CRGT #BCI #NeuroTech

#Vivani #Cortigent is shifting development focus for the #Orion brain implant from a visual cortical prosthesis for the blind towards a stroke recovery system https://www.sec.gov/Archives/edgar/data/1958489/000175392624000605/g084143_s1a.htm $VANI $EYES $CRGT #BCI #NeuroTech

#Vivani #Cortigent is shifting development focus for the #Orion brain implant from a visual cortical prosthesis for the blind towards a stroke recovery system https://www.sec.gov/Archives/edgar/data/1958489/000175392624000605/g084143_s1a.htm $VANI $EYES $CRGT #BCI #NeuroTech

#Vivani #Cortigent is shifting development focus for the #Orion brain implant from a visual cortical prosthesis for the blind towards a stroke recovery system https://www.sec.gov/Archives/edgar/data/1958489/000175392624000605/g084143_s1a.htm $VANI $EYES $CRGT #BCI #NeuroTech

#Vivani #Cortigent is shifting development focus for the #Orion brain implant from a visual cortical prosthesis for the blind towards a stroke recovery system https://www.sec.gov/Archives/edgar/data/1958489/000175392624000605/g084143_s1a.htm $VANI $EYES $CRGT #BCI #NeuroTech

Given the current market situation, the sole takeover offer for #Pixium Vision likely comes from #Vivani Medical subsidiary #Cortigent, and will be rather low because their focus has shifted from retinal implants to brain implants for vision (Orion) with small staff; $VANI $CRGT $ALPIX

Given the current market situation, the sole takeover offer for #Pixium Vision likely comes from #Vivani Medical subsidiary #Cortigent, and will be rather low because their focus has shifted from retinal implants to brain implants for vision (Orion) with small staff; $VANI $CRGT $ALPIX

Given the current market situation, the sole takeover offer for #Pixium Vision likely comes from #Vivani Medical subsidiary #Cortigent, and will be rather low because their focus has shifted from retinal implants to brain implants for vision (Orion) with small staff; $VANI $CRGT $ALPIX

Given the current market situation, the sole takeover offer for #Pixium Vision likely comes from #Vivani Medical subsidiary #Cortigent, and will be rather low because their focus has shifted from retinal implants to brain implants for vision (Orion) with small staff; $VANI $CRGT $ALPIX

Given the current market situation, the sole takeover offer for #Pixium Vision likely comes from #Vivani Medical subsidiary #Cortigent, and will be rather low because their focus has shifted from retinal implants to brain implants for vision (Orion) with small staff; $VANI $CRGT $ALPIX

#Vivani Medical subsidiary #Cortigent to present #Orion clinical study results at The Eye and The Chip world research congress on artificial vision October 8-10 https://www.businesswire.com/news/home/20230905022146/en/Vivani-Medical-Subsidiary-Cortigent-to-Present-Orion-Clinical-Study-Results-at-The-Eye-and-The-Chip-World-Research-Congress-on-Artificial-Vision-October-8-10 $VANI $EYES $CGTR #BCI #NeuroTech #blind #blindness, #brain #implant, Orion visual cortical prosthesis system.

#Vivani Medical subsidiary #Cortigent to present #Orion clinical study results at The Eye and The Chip world research congress on artificial vision October 8-10 https://www.businesswire.com/news/home/20230905022146/en/Vivani-Medical-Subsidiary-Cortigent-to-Present-Orion-Clinical-Study-Results-at-The-Eye-and-The-Chip-World-Research-Congress-on-Artificial-Vision-October-8-10 $VANI $EYES $CGTR #BCI #NeuroTech #blind #blindness, #brain #implant, Orion visual cortical prosthesis system.

#Vivani Medical subsidiary #Cortigent to present #Orion clinical study results at The Eye and The Chip world research congress on artificial vision October 8-10 https://www.businesswire.com/news/home/20230905022146/en/Vivani-Medical-Subsidiary-Cortigent-to-Present-Orion-Clinical-Study-Results-at-The-Eye-and-The-Chip-World-Research-Congress-on-Artificial-Vision-October-8-10 $VANI $EYES $CGTR #BCI #NeuroTech #blind #blindness, #brain #implant, Orion visual cortical prosthesis system.

#Vivani Medical subsidiary #Cortigent to present #Orion clinical study results at The Eye and The Chip world research congress on artificial vision October 8-10 https://www.businesswire.com/news/home/20230905022146/en/Vivani-Medical-Subsidiary-Cortigent-to-Present-Orion-Clinical-Study-Results-at-The-Eye-and-The-Chip-World-Research-Congress-on-Artificial-Vision-October-8-10 $VANI $EYES $CGTR #BCI #NeuroTech #blind #blindness, #brain #implant, Orion visual cortical prosthesis system.

#Vivani Medical subsidiary #Cortigent to present #Orion clinical study results at The Eye and The Chip world research congress on artificial vision October 8-10 https://www.businesswire.com/news/home/20230905022146/en/Vivani-Medical-Subsidiary-Cortigent-to-Present-Orion-Clinical-Study-Results-at-The-Eye-and-The-Chip-World-Research-Congress-on-Artificial-Vision-October-8-10 $VANI $EYES $CGTR #BCI #NeuroTech #blind #blindness, #brain #implant, Orion visual cortical prosthesis system.

Second Sight’s implant technology gets a second chance https://spectrum.ieee.org/bionic-eye by @meharris; from Argus II retinal implant and Orion I visual cortical prosthesis to brain implant for stroke rehabilitation; still 60 electrodes so repurposing existing tech; #Vivani $VANI, #Cortigent $CRGT #BCI #NeuroTech

Second Sight’s implant technology gets a second chance https://spectrum.ieee.org/bionic-eye by @meharris; from Argus II retinal implant and Orion I visual cortical prosthesis to brain implant for stroke rehabilitation; still 60 electrodes so repurposing existing tech; #Vivani $VANI, #Cortigent $CRGT #BCI #NeuroTech

Second Sight’s implant technology gets a second chance https://spectrum.ieee.org/bionic-eye by @meharris; from Argus II retinal implant and Orion I visual cortical prosthesis to brain implant for stroke rehabilitation; still 60 electrodes so repurposing existing tech; #Vivani $VANI, #Cortigent $CRGT #BCI #NeuroTech

Second Sight’s implant technology gets a second chance https://spectrum.ieee.org/bionic-eye by @meharris; from Argus II retinal implant and Orion I visual cortical prosthesis to brain implant for stroke rehabilitation; still 60 electrodes so repurposing existing tech; #Vivani $VANI, #Cortigent $CRGT #BCI #NeuroTech

Second Sight’s implant technology gets a second chance https://spectrum.ieee.org/bionic-eye by @meharris; from Argus II retinal implant and Orion I visual cortical prosthesis to brain implant for stroke rehabilitation; still 60 electrodes so repurposing existing tech; #Vivani $VANI, #Cortigent $CRGT #BCI #NeuroTech

#Vivani Medical, Inc. subsidiary #Cortigent reports 5-year early feasibility study update for the #Orion Visual Cortical Prosthesis System https://www.businesswire.com/news/home/20230711035392/en/Vivani-Medical-Inc.-Subsidiary-Cortigent-Reports-5-Year-Early-Feasibility-Study-Update-for-the-Orion%C2%AE-Visual-Cortical-Prosthesis-System Of 6, "Three subjects have had the devices removed (explanted) for various reasons unrelated to device safety or reliability"; #BCI #NeuroTech #blind #blindness $VANI $CRGT

#Vivani Medical, Inc. subsidiary #Cortigent reports 5-year early feasibility study update for the #Orion Visual Cortical Prosthesis System https://www.businesswire.com/news/home/20230711035392/en/Vivani-Medical-Inc.-Subsidiary-Cortigent-Reports-5-Year-Early-Feasibility-Study-Update-for-the-Orion%C2%AE-Visual-Cortical-Prosthesis-System Of 6, "Three subjects have had the devices removed (explanted) for various reasons unrelated to device safety or reliability"; #BCI #NeuroTech #blind #blindness $VANI $CRGT

#Vivani Medical, Inc. subsidiary #Cortigent reports 5-year early feasibility study update for the #Orion Visual Cortical Prosthesis System https://www.businesswire.com/news/home/20230711035392/en/Vivani-Medical-Inc.-Subsidiary-Cortigent-Reports-5-Year-Early-Feasibility-Study-Update-for-the-Orion%C2%AE-Visual-Cortical-Prosthesis-System Of 6, "Three subjects have had the devices removed (explanted) for various reasons unrelated to device safety or reliability"; #BCI #NeuroTech #blind #blindness $VANI $CRGT

#Vivani Medical, Inc. subsidiary #Cortigent reports 5-year early feasibility study update for the #Orion Visual Cortical Prosthesis System https://www.businesswire.com/news/home/20230711035392/en/Vivani-Medical-Inc.-Subsidiary-Cortigent-Reports-5-Year-Early-Feasibility-Study-Update-for-the-Orion%C2%AE-Visual-Cortical-Prosthesis-System Of 6, "Three subjects have had the devices removed (explanted) for various reasons unrelated to device safety or reliability"; #BCI #NeuroTech #blind #blindness $VANI $CRGT

#Vivani Medical, Inc. subsidiary #Cortigent reports 5-year early feasibility study update for the #Orion Visual Cortical Prosthesis System https://www.businesswire.com/news/home/20230711035392/en/Vivani-Medical-Inc.-Subsidiary-Cortigent-Reports-5-Year-Early-Feasibility-Study-Update-for-the-Orion%C2%AE-Visual-Cortical-Prosthesis-System Of 6, "Three subjects have had the devices removed (explanted) for various reasons unrelated to device safety or reliability"; #BCI #NeuroTech #blind #blindness $VANI $CRGT

#Vivani Medical announces $1 million NIH grant funding to support #Cortigent's ongoing #Orion clinical study https://www.businesswire.com/news/home/20230404005438/en/ #BCI #blindness $VANI $EYES

#Vivani Medical announces $1 million NIH grant funding to support #Cortigent's ongoing #Orion clinical study https://www.businesswire.com/news/home/20230404005438/en/ #BCI #blindness $VANI $EYES

#Vivani Medical announces $1 million NIH grant funding to support #Cortigent's ongoing #Orion clinical study https://www.businesswire.com/news/home/20230404005438/en/ #BCI #blindness $VANI $EYES

#Vivani Medical announces $1 million NIH grant funding to support #Cortigent's ongoing #Orion clinical study https://www.businesswire.com/news/home/20230404005438/en/ #BCI #blindness $VANI $EYES

#Vivani Medical announces $1 million NIH grant funding to support #Cortigent's ongoing #Orion clinical study https://www.businesswire.com/news/home/20230404005438/en/ #BCI #blindness $VANI $EYES

Secondo me questa è una delle cioccolate migliori… #VIVANI #NATURASÌ